Pericyazine 2.5mg tablets

国: イギリス

言語: 英語

ソース: MHRA (Medicines & Healthcare Products Regulatory Agency)

有効成分:

Pericyazine

から入手可能:

DE Pharmaceuticals

ATCコード:

N05AC01

INN（国際名）:

Pericyazine

投薬量:

2.5mg

医薬品形態:

Oral tablet

投与経路:

Oral

クラス:

No Controlled Drug Status

処方タイプ:

Valid as a prescribable product

製品概要:

BNF: 04020100

情報リーフレット

PACKAGE LEAFLET:
INFORMATION FOR THE PATIENT
PERICYAZINE 2.5MG TABLETS
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
INFORMATION IMPORTANT FOR YOU.

Keep this leaflet. You may need to read it again

If you have any further questions, ask your doctor or pharmacist

This medicine has been prescribed for you. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This
includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1. What pericyazine is and what it is used for
2. What you need to know before you take pericyazine
3. How to take pericyazine
4. Possible side effects
5. How to store pericyazine
6. Contents of the pack and other information
1. WHAT PERICYAZINE IS AND WHAT IT IS USED FOR
The name of your medicine is Pericyazine 2.5mg Tablets (referred to as
pericyazine throughout
this leaflet).This belongs to a group of medicines called
‘phenothiazines’. It works by blocking the
effect of a chemical in the brain. It can be used for:

Schizophrenia

The short term treatment of anxiety, agitation and violent or
dangerously impulsive
behaviour when used with other medicines
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE PERICYAZINE
DO NOT TAKE THIS MEDICINE AND TELL YOUR DOCTOR IF:

You are allergic (hypersensitive) to pericyazine or any of the other
ingredients in this
medicine (listed in Section 6)

Signs of an allergic reaction include: a rash, swallowing or breathing
problems, swelling
of your lips, face, throat or tongue

You are pregnant, might become pregnant or think you may be pregnant
(see Section
below: ‘Pregnancy and breast-feeding’)

Do not take this medicine if any of the above apply to you. If you are
not sure, talk to your
doctor or pharmacist before taking pericyazine.
WARNINGS AND PRECAUTIONS
TALK TO YOUR DOCTOR OR PHARMACIST BEFORE YOU TAKE THIS MEDICINE IF:

Yo

製品の特徴

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Pericyazine 2.5mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 2.5mg pericyazine.
Excipients of with known effect:
Methyl hydroxybenzoate: Each 2.5mg tablet contains 0.001 mg benzoate
salt.
Lactose: Each 2.5mg tablet contains 51.1mg lactose.
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Pericyazine 2.5mg Tablets: Circular, very pale lime-yellow tablet,
with one
face impressed ‘S171’ just inside the perimeter. Break-line on
reverse.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
a)
In adults with schizophrenia or other psychoses, for the treatment of
symptoms or prevention of relapse.
b)
In anxiety, psychomotor agitation, violent or dangerously impulsive
behaviour. Pericyazine is used as an adjunct to the short-term
management of
these conditions.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_ Severe conditions _
_Indication (a) _
_ _
Adults:_ _Initially 75 mg per day in divided doses. Dosage should be
increased
by 25 mg per day at weekly intervals until the optimum effect is
achieved.
Maintenance therapy would not normally be expected to exceed 300 mg
per
day.
Elderly: _ _Initially 15-30 mg per day in divided doses. If this is
well tolerated
the dosage may be increased if necessary for optimum control of
behaviour.
_Mild or moderate conditions _
_ _
_Indication (b) _
_ _
Adults: Initially 15-30 mg daily, divided into two portions with a
larger dose
being given in the evening.
Elderly: 5-10 mg per day is suggested as a starting dose. It may be
divided so
that a larger portion is given in the evening. Half or quarter the
normal adult
dose may be sufficient for maintenance therapy.
Pericyazine tablets are not recommended for children.
Method of administration
Oral.
Dosage requirement varies with the individual and the severity of the
condition being treated. Initial dosage should be low with progressive
increases until the desired response is obtained, after which dosage
should be
adj